Presents a study on rapid tapering of cyclosporin to maximize the grant-versus-leukemia effect. Methodology used in the study; Review of medical cases; Discussion on the results of the study.
Presents a study on rapid tapering of cyclosporin to maximize the grant-versus-leukemia effect. Methodology used in the study; Review of medical cases; Discussion on the results of the study.
Diabetes mellitus is the fourth leading cause of death by disease in the United States. Metformin hydrochloride was developed for the treatment of type 2 diabetes during the late 1950s (1) and was first marketed world...
详细信息
Diabetes mellitus is the fourth leading cause of death by disease in the United States. Metformin hydrochloride was developed for the treatment of type 2 diabetes during the late 1950s (1) and was first marketed worldwide in 1959 (2). The Food and Drug Administration approved its use in the United States in 1995 (3,4). Its mechanism of action is not known, but it is believed to cause inhibition of gluconeogenesis, thus eliminating glucotoxicity and reversing insulin resistance (1,4). It has no effect on insulin release.
Examines the impact of intravenous lidocaine on the treatment of pain in adiposis dolorosa. Characterization of the disorder; Elimination of lipomas; Elevation of serum cholesterol and triglycerides.
Examines the impact of intravenous lidocaine on the treatment of pain in adiposis dolorosa. Characterization of the disorder; Elimination of lipomas; Elevation of serum cholesterol and triglycerides.
暂无评论